Clinical Data, Comorbidities, and Mortality of COVID-19 in the State of Guanajuato, Mexico until May 20, 2020

Nicolás Padilla-Raygoza, Efraín Navarro-Olivos, María de Jesús Gallardo-Luna, Francisco J Magos-Vázquez, Daniel Alberto Díaz-Martínez, Cuauhtémoc Sandoval-Salazar, Luis Antonio Díaz-Becerril

Abstract


Introduction: In December 2019, cases of pneumonia of unknown cause arose in Wuhan, China. The causative agent was subsequently identified as 2019-nCoV and later called SARS-CoV-2. In Mexico, since January 2020 when the first cases were reported, the spread of the infection has occurred throughout the country. The state of Guanajuato, which is located in the center of the country, has taken isolation measures and closed public places in March 2020. The objective of this study was to analyze the evolution, symptoms, co-morbidities and deaths due to confirmed cases of COVID-19.

Methods: An ecological study was designed from the database of confirmed cases of COVID-19 in the state of Guanajuato. Odds ratios and 95% confidence intervals were calculated for symptoms and co-morbidities in deaths of confirmed cases. Logistic regression models were generated adjusting for age group and gender.

Results: Among the 838 confirmed cases in the state, cases with dyspnea and cyanosis showed more significant effect on death. Age group and gender had little involvement as confounders. For practically all comorbidities (including diabetes, hypertension, cardiovascular disease, chronic kidney disease, and immunosuppression), there was a significant effect (odds ratio greater than 2) on mortality from COVID-19. Age group showed a confounding effect on comorbidities and death, but not gender.

Conclusion: The confirmed cases had more than twice the possibility of having comorbidities, compared with those who did not die.


Keywords


SARS-CoV-2; COVID-19; Population; Deaths; Clinical data; Comorbidities

Full Text:

PDF

References


World Health Organization. Rolling updates on coronavirus disease (COVID-19). World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen . Updated 7 May 2020. Accessed: June 21, 2020.

Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020; 92(4):401-402. Doi: https://doi.org/10.1002/jmv.25678

Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020; 91: 264-66 Doi: https://doi.org/10.1016/j.ijid.2020.01.009

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223):497-506 Doi: https://doi.org/10.1016/S0140-6736(20)30183-5

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet.2020; 395(10223): 507-513 https://doi.org/10.1016/S0140-6736(20)30211-7

Yoo JH, Hong ST. The outbreak cases with the novel coronavirus suggest upgraded quarantine and isolation in Korea. J Korean Med Sci. 2020;35(5): e62 Doi: https://doi.org/10.3346/jkms.2020.35.e62

Carlos WG, De la Cruz C, Cao B, Pasnick S, Jamil S. Novel Wuhan (2019-CoV) coronavirus. Am J Respi Crit Care Med. 2020; 201(4): 7-8 Doi: https://doi.org/10.1164/rccm.2014P7

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579: 270-273. https://doi.org/10.1038/s41586-020-2012-7

Zhu N, Zhang D, Wang W, Li X. Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727:737. Doi: https://doi.org/10.1056/NEJMoa2001017

World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance. World Health Organization. 2020. https://www.who.int/publications-detail/clinical-management-ofsevere-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected . Accessed June 21, 2020.

Huang C, Wuang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223): 497-506 Doi: https://doi.org/10.1016/S0140-6736(20)30183-5

Secretaría de Salud. Datos-Abiertos Bases históricas. 6 mayo 2020. Available in: https://www.gob.mx/salud/documentos/datos-abiertos-bases-historicas-direccion-general-de-epidemiologia Accessed May 20, 2020

INEGI. Mexico en Cifras. Guanajuato. INEGI. https://www.inegi.org.mx/app/areasgeograficas/?ag=11, Accessed June 21, 2020

INEGI-Población. INEGI. https://www.inegi.org.mx/temas/estructura/. Accessed: June 21, 2020

Departamento de Epidemiología de la Dirección de Servicios de Salud. Sistema Nacional de Vigilancia Epidemiológica, Dirección General de Epidemiología, Secretaría de Salud. Available in: http://www.sinave.gob.mx/ . 2020. Accessed May 21, 2020.

Matrajt L, Leung T. Evaluating the effectiveness of social distancing interventions to delay or flatten the epidemic curve of Coronavirus disease. Emerg. Infect. Dis. 2020; 26(8). Doi: http://doi.org/10.3201/eid2608.201093

Li L, Yang Z, Dang Z, Meng C, Huang J, Meng H, et al. Propagation analysis and prediction of the COVID-19. Infectious Disease Modelling. 2020; 3: 282-292. Doi: http://doi.org/10.1016/j.idm.2020.03.002

Padilla-Raygoza N, Sandoval-Salazar C, Díaz-Becerril LA, Beltran-Campos V, Díaz-Martínez DA, Navarro-Olivos E, et al. Update of the Evolution of SARS-CoV-2 infection, COVID-19, and mortality in Mexico until May 15, 2020: An Ecological Study. International Journal of Tropical Disease & Health, 2020; 41(5): 36-45. Doi: https://doi.org/10.9734/IJTDH/2020/v41i/530277 .

World Health Organization. Coronavirus disease 2019 (COVID-19). Situation Report – 85, April 14, 2020. Available in: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200414-sitrep-85-covid-19.pdf?sfvrsn=7b8629bb_4 Accessed: June 21, 2020.

Guan WJ, Ni ZY, Hu Y, Laing WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382:1708-1720. Doi: https://doi.org/10.1056/NEJMoa2002032

Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, et al. Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage. medRxiv. 2020. Doi: https://doi.org/10.1101/2020.02.10.20021584

Chen H, Gua J, Wang C, Lua F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet. 2020; 395 (10226): 809-815. Doi: https://doi.org/10.1016/S0140-6736(20)30360-3

Huang C, Wuang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223): 497-506 Doi: https://doi.org/10.1016/S0140-6736(20)30183-5




DOI: https://doi.org/10.5195/cajgh.2020.527

Refbacks

  • There are currently no refbacks.




Copyright (c) 2020 Nicolas Padilla-Raygoza, Efrain Navarro-Olivos, Maria de Jesus Gallardo-Luna, Francisco J Magos-Vazquez, Daniel Alberto Díaz-Martinez, Cuauhtémoc Sandoval- Salazar, Luis Antonio Diaz-Becerril

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.